Key Events This Week
15 Jun: Stock opens at Rs.257.80, up 1.14% with Sensex rising 1.19%
18 Jun: Stock surges 3.79% to Rs.271.45 amid downgrade announcement
19 Jun: Downgrade to Strong Sell rating announced; stock closes at Rs.270.35 (-0.41%)
19 Jun: Valuation grade shifts from Very Attractive to Attractive

Everest Organics Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends
2026-06-19 08:07:08Everest Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 June 2026. Despite an upgrade in valuation metrics, the company’s overall financial health and market performance continue to raise concerns, prompting a cautious stance among investors.
Read full news article
Everest Organics Ltd Valuation Shifts Signal Changing Market Sentiment
2026-06-19 08:00:07Everest Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, moving from very attractive to attractive territory. Despite a challenging year-to-date performance, the stock’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point relative to its historical averages and peer group, prompting a reassessment of its investment appeal.
Read full news article
Everest Organics Ltd is Rated Sell
2026-06-15 10:11:45Everest Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read full news articleEverest Organics Declines 11.00%: Valuation Appeal Amidst Mixed Financial Signals
2026-06-14 16:02:17
Key Events This Week
1 June: Stock opens at Rs.261.20, down 2.65% amid broader market weakness
2 June: Valuation metrics improve, signalling renewed price attractiveness
3 June: Downgrade to Sell rating announced, stock falls 5.34%
4 June: Price rebounds 6.20% on improved operational results
5 June: Week closes at Rs.238.80, down 3.90% on the day

Everest Organics Ltd Downgraded to Sell Amid Mixed Financial and Valuation Signals
2026-06-04 08:14:54Everest Organics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 3 June 2026, reflecting a nuanced shift across key parameters including quality, valuation, financial trend, and technicals. Despite a challenging recent performance, the company’s valuation metrics and certain financial indicators have improved, prompting a reassessment of its market stance.
Read full news article
Everest Organics Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges
2026-06-02 08:00:29Everest Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive price level. Despite recent price declines and a challenging year-to-date performance, the company’s valuation metrics now present a compelling case for investors seeking value in a volatile market.
Read full news article
Everest Organics Q4 FY26: Margin Recovery Masks Underlying Weakness
2026-05-30 20:45:49Everest Organics Ltd., a Hyderabad-based active pharmaceutical ingredients manufacturer with a market capitalisation of ₹252.00 crores, reported a net profit of ₹2.63 crores for Q4 FY26, marking a significant sequential recovery from ₹0.36 crores in Q3 FY26. However, the stock has plummeted 38.88% over the past year, significantly underperforming the Sensex's 8.40% decline, as investors remain concerned about deteriorating fundamentals and anaemic long-term growth.
Read full news article
Everest Organics Ltd Upgraded to Sell on Technical Improvements Despite Lingering Fundamental Concerns
2026-05-26 08:27:07Everest Organics Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators amid ongoing fundamental challenges. While the company’s financial trend shows some positive quarterly performance, concerns over long-term profitability and debt servicing continue to weigh on investor sentiment.
Read full news articleAnnouncement under Regulation 30 (LODR)-Cessation
22-Jun-2026 | Source : BSEResignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSENewspaper publication of Audited Financial Results for the quarter and year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Change in Directorate
29-May-2026 | Source : BSEAppointment of Mr. Narra Venkata Ramana as Additional Director in the Board Meeting held today i.e. May 29 2026.
Corporate Actions
No Upcoming Board Meetings
Everest Organics Ltd has declared 5% dividend, ex-date: 15 Sep 22
No Splits history available
No Bonus history available
No Rights history available






